The early innings of the obesity landscape is starting to take shape, and it seems to be forming similar patterns...
Read NowModular Medical (MODD) announced the 510(k) submission of their MODD1 insulin pump to the FDA last week. On average, the FDA takes approximately...
PremiumInsights - Aerpio (ARPO) released their Q3 earnings and business update yesterday. The company remains on track to report Phase 2 data in glaucoma in “December or early in … Continue Reading
PremiumResearch - Affimed (AFMD) announced a licensing agreement with Roivant Sciences Monday after-market and Q3 business update this morning. Below we will outline the highlights from Q3 update and collaboration with Roivant. First, … Continue Reading
PremiumInsights - Pfizer (PFE) and BioNTech (BTNX) revealed that their COVID-19 vaccine was >90% effective in preventing the virus, compared to patients receiving placebo. This is a … Continue Reading
Read nowInsights - Tomorrow, Friday November 6, the FDA will hold an ADCOM for Biogen’s (BIIB) aducanumab. Aducanumab is a beta-amyloid drug for Alzheimer’s Disease that can receive … Continue Reading
PremiumInsights - Affimed’s (AFMD) ASH abstract for AFM13 was released today. The abstract (see here) covers AFM13 Phase 1 in relapsed/refractory CD30+ lymphoma patients. Affimed refers to this … Continue Reading
PremiumResearch - Iovance (IOVA) is up 35% since we opened a position on news that the company’s BLA was going to be delayed (read thesis here). This was … Continue Reading
PremiumInsights - Earlier this week, Affimed announced a collaboration with Korean company NKMax to investigate the combination of AFM24, an EGFR engager, with autologous NK cell product … Continue Reading
Premium
